Abstract

Lowering cholesterol levels in men who have hypercholesterolaemia but no symptoms of cardiovascular disease can significantly reduce the risk of developing coronary heart disease (CHD), according to the results of the first major study of an HMG-CoA reductase inhibitor in primary prevention. The results of this landmark trial, which is referred to as the West of Scotland Coronary Prevention Study (WOSCOPS), were presented at the 68th Scientific Sessions of the American Heart Association [ Anaheim, US; November 1995 ], and have also been published in a recent issue of the NEJM. 1

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.